Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Knox

Showing results (581-590 of 829) with videos related to

Pageof 83
Sort By:
Hepatology (Baltimore, Md.)|December 26, 2015
Safety and efficacy of ledipasvir/sofosbuvir for the treatment of genotype 1 hepatitis C in subjects aged 65 years or olderSammy Saab, Sarah H Park, Masashi Mizokami, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 21, 2004
BL-1249 [(5,6,7,8-tetrahydro-naphthalen-1-yl)-[2-(1H-tetrazol-5-yl)-phenyl]-amine]: a putative potassium channel opener with bladder-relaxant propertiesSvetlana Tertyshnikova, Ronald J Knox, Mary Jane Plym, et al.
Liver Cancer|October 22, 2024
Characterization of Tumor Responses in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib in the Phase 3 Randomized Trial: REFLECTRichard S Finn, Shukui Qin, Fabio Piscaglia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Phase I study of individualized stereotactic body radiotherapy of liver metastasesMark T Lee, John J Kim, Robert Dinniwell, et al.
Cancer|June 10, 2010
Phase 2 trial of preoperative irinotecan plus cisplatin and conformal radiotherapy, followed by surgery for esophageal cancerJennifer J Knox, Rebecca Wong, Antonio L Visbal, et al.
The Prostate|August 12, 2014
Retreatment of men with metastatic castrate-resistant prostate cancer with abirateroneRaya Leibowitz-Amit, Nimira Alimohamed, Francisco E Vera-Badillo, et al.
Investigational New Drugs|October 17, 2014
A phase II trial of bevacizumab plus temsirolimus in patients with advanced hepatocellular carcinomaJennifer J Knox, Rui Qin, Jonathan R Strosberg, et al.
The Journal of Infectious Diseases|June 3, 2025
B-Cell Subset Representation Predicts SARS-CoV-2 Vaccine Response in Solid Organ Transplant RecipientsJames J Knox, Ingi Lee, Emily A Blumberg, et al.
International Journal of Radiation Oncology, Biology, Physics|July 7, 2018
Baseline Albumin-Bilirubin (ALBI) Score in Western Patients With Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy (SBRT)Louise J Murray, Jenna Sykes, James Brierley, et al.
Journal of Gastrointestinal Oncology|May 9, 2017
Long term responders to palliative chemotherapy for advanced biliary tract cancerMark K Doherty, Mairéad G McNamara, Priya Aneja, et al.
Pageof 83

Showing results (581-590 of 829) with videos related to

Sort By:
Pageof 83
Hepatology (Baltimore, Md.)|December 26, 2015
Safety and efficacy of ledipasvir/sofosbuvir for the treatment of genotype 1 hepatitis C in subjects aged 65 years or olderSammy Saab, Sarah H Park, Masashi Mizokami, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 21, 2004
BL-1249 [(5,6,7,8-tetrahydro-naphthalen-1-yl)-[2-(1H-tetrazol-5-yl)-phenyl]-amine]: a putative potassium channel opener with bladder-relaxant propertiesSvetlana Tertyshnikova, Ronald J Knox, Mary Jane Plym, et al.
Liver Cancer|October 22, 2024
Characterization of Tumor Responses in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib in the Phase 3 Randomized Trial: REFLECTRichard S Finn, Shukui Qin, Fabio Piscaglia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Phase I study of individualized stereotactic body radiotherapy of liver metastasesMark T Lee, John J Kim, Robert Dinniwell, et al.
Cancer|June 10, 2010
Phase 2 trial of preoperative irinotecan plus cisplatin and conformal radiotherapy, followed by surgery for esophageal cancerJennifer J Knox, Rebecca Wong, Antonio L Visbal, et al.
The Prostate|August 12, 2014
Retreatment of men with metastatic castrate-resistant prostate cancer with abirateroneRaya Leibowitz-Amit, Nimira Alimohamed, Francisco E Vera-Badillo, et al.
Investigational New Drugs|October 17, 2014
A phase II trial of bevacizumab plus temsirolimus in patients with advanced hepatocellular carcinomaJennifer J Knox, Rui Qin, Jonathan R Strosberg, et al.
The Journal of Infectious Diseases|June 3, 2025
B-Cell Subset Representation Predicts SARS-CoV-2 Vaccine Response in Solid Organ Transplant RecipientsJames J Knox, Ingi Lee, Emily A Blumberg, et al.
International Journal of Radiation Oncology, Biology, Physics|July 7, 2018
Baseline Albumin-Bilirubin (ALBI) Score in Western Patients With Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy (SBRT)Louise J Murray, Jenna Sykes, James Brierley, et al.
Journal of Gastrointestinal Oncology|May 9, 2017
Long term responders to palliative chemotherapy for advanced biliary tract cancerMark K Doherty, Mairéad G McNamara, Priya Aneja, et al.
Pageof 83